Weaver Consulting Group Novartis Ag Transaction History

Weaver Consulting Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$78.07 - $94.43 $32,008 - $38,716	-410 Closed	0 $0
Q2 2020 Jul 24, 2020	BUY	$80.93 - $91.1 $10,520 - $11,843	130 Added 46.43%	410 $36,000
Q1 2020 Apr 28, 2020	BUY	$70.67 - $99.01 $3,250 - $4,554	46 Added 19.66%	280 $23,000
Q1 2019 Jun 19, 2019	BUY	$75.32 - $86.15 $17,624 - $20,159	234 New	234 $21,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.